ArticleIntensive care medicine experimental2025

A phase I trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenously administered low-anticoagulant heparin (M6229) in critically ill sepsis patients.

Niels van Mourik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.